That's right, POS.
The common the procedure becomes the less retail margin there is.
So the 5000 pound treatment becomes 1000 pounds (thus opening up to even more people)
Avita can still sell the product for whatever it wants.
It's the retail margins that get hit with poularity.
It's the work that is done now that dictates just how successful ReCell will be in 3 years time.
onemedplace video, page-47
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.73 |
Change
-0.200(6.83%) |
Mkt cap ! $185.9M | |||
| Open | High | Low | Value | Volume |
| $2.70 | $2.77 | $2.63 | $1.420M | 521.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3075 | $2.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.73 | 45063 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |